MCM
ARKG icon

MAI Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

MAI Capital Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,410
Closed -$37.3K – 2252
2026
Q1 		$37.3K Sell
1,410
-109
-7% -$3.19K ﹤0.01% 2420
2025
Q4 		$44K Sell
1,519
-120
-7% -$3.6K ﹤0.01% 2088
2025
Q3 		$45.5K Buy
1,639
+139
+9% +$3.51K ﹤0.01% 1985
2025
Q2 		$36.5K Sell
1,500
-405
-21% -$8.88K ﹤0.01% 2035
2025
Q1 		$39.6K Buy
1,905
+19
+1% +$477 ﹤0.01% 1862
2024
Q4 		$44.4K Buy
+1,886
New +$46.4K ﹤0.01% 1840
2022
Q1 		– Sell
-3,655
Closed -$224K – 929
2021
Q4 		$224K Buy
+3,655
New +$253K ﹤0.01% 794

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MAI Capital Management's ARKG Position: Q2 2026 in Review

MAI Capital Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 1,410 shares — an estimated $37.3K sold.

MAI Capital Management first reported a position in ARKG in Q4 2021 and held it in 7 quarters. The position peaked at $224K in Q4 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • MAI Capital Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 1,410 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $37.3K.
  • MAI Capital Management first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 7 quarters.
  • MAI Capital Management's ARK Genomic Revolution ETF position peaked at $224K in Q4 2021.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.